Literature DB >> 2810292

Impact of NSAIDS on murine antigen induced arthritis. I. Investigation of antiinflammatory and chondroprotective effects.

B J de Vries1, W B van den Berg.   

Abstract

The well known nonsteroidal antiinflammatory drugs (NSAID) diclofenac, piroxicam and tiaprofenic acid as well as the corticosteroid prednisolone, were examined for their effect on injury to knee joint structures evoked by a developing murine antigen induced arthritis. To ensure the human therapeutic dose, each drug was given twice a day per os in 3 different dosage regimes. The severity of arthritis was monitored with 99mTc-uptake measurements. After 3 weeks, mice were sacrificed and knee joints were examined histologically. All drugs exhibited, in comparable extent, antiinflammatory effects in terms of swelling. Grading of joint damage was focused on cartilage harm and chondrocyte activity. Only prednisolone provided sufficient protection and seemed to stimulate repair activity. The NSAID had no clear beneficial or adverse influences on affected cartilage. Apparently, under these experimental circumstances, only prednisolone functions chondroprotectively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2810292

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  3 in total

1.  The relation between cartilage damage and osteophyte size in a murine model for osteoarthritis in the knee.

Authors:  G J van Osch; P M van der Kraan; A A van Valburg; W B van den Berg
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

2.  Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment.

Authors:  W B van den Berg; L A Joosten; M Helsen; F A van de Loo
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

Review 3.  Tiaprofenic acid. A reappraisal of its pharmacological properties and use in the management of rheumatic diseases.

Authors:  G L Plosker; A J Wagstaff
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.